Aclairo Pharmaceutical Development Group - Ownership and Business Overview

Business ServicesCompany

Aclairo Pharmaceutical Development Group Ownership

Who owns Aclairo Pharmaceutical Development Group?

Aclairo Pharmaceutical Development Group is owned by Experimental Pathology Laboratories. It was acquired on January 13, 2016.

Aclairo Pharmaceutical Development Group Business Overview

Where is Aclairo Pharmaceutical Development Group headquartered?

Aclairo Pharmaceutical Development Group is headquartered in Vienna, Virginia.

What sector is Aclairo Pharmaceutical Development Group in?

Aclairo Pharmaceutical Development Group is a business services company.

When was Aclairo Pharmaceutical Development Group founded?

Aclairo Pharmaceutical Development Group was founded in 2004.

Business Services M&A Summary in 2016

Out of 60 sectors in the Mergr database, business services ranked 4 in number of deals in 2016. The largest business services acquisition in 2016 was Pentair - Valves & Controls Business - which was acquired by Emerson Electric for $3.2B.

Join Mergr to view all 635 acquisitions of business services companies in 2016, including 89 acquisitions by private equity firms, and 546 by strategics.

Aclairo Pharmaceutical Development Group, Inc.

1950 Old Gallows Road, Suite 300,
Vienna, Virginia 22182
United States,
(703) 506-6760
www.aclairo.com

Aclairo Pharmaceutical Development Group, Inc. is an independent and objective nonclinical and regulatory advice to the pharmaceutical industry.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.